Gene: TTC39A
Official Full Name: tetratricopeptide repeat domain 39Aprovided by HGNC
Gene Summary: Located in centrosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30047 | TTC39A Knockout cell line (HCT 116) | Human | TTC39A | 1:2~1:4 | Negative | Online Inquiry |
KO30048 | TTC39A Knockout cell line (HEK293) | Human | TTC39A | 1:3~1:6 | Negative | Online Inquiry |
KO30049 | TTC39A Knockout cell line (A549) | Human | TTC39A | 1:3~1:4 | Negative | Online Inquiry |
TTC39A Gene Knockout Cell Lines are specially developed cellular models designed to study the functional role of the TTC39A gene through the innovative application of CRISPR-Cas9 gene editing technology. In these knockout cell lines, the TTC39A gene has been effectively disrupted, allowing researchers to observe the biological consequences of its absence in a controlled environment. The key mechanism involves the introduction of insertions or deletions at the target gene locus, leading to a frameshift mutation that results in a non-functional protein product, thus facilitating the downstream study of gene function, pathway interactions, and disease mechanisms.
The scientific importance of TTC39A Gene Knockout Cell Lines is underscored by the relevance of the TTC39A gene in various biological processes, including vesicular transport and cellular signaling pathways. By utilizing these knockout models, researchers can uncover the gene's roles in diseases such as cancer, neurological disorders, and metabolic syndromes. These studies not only advance our understanding of fundamental biological functions but also open pathways for targeted therapeutic approaches.
One of the unique selling points of our TTC39A Gene Knockout Cell Lines is their unparalleled specificity and reproducibility compared to traditional gene silencing techniques, such as RNA interference. Researchers often face challenges with off-target effects in RNAi methods, whereas CRISPR-Cas9 provides precise genetic modifications, reducing the likelihood of confounding results. Additionally, our cell lines are readily characterized, validated, and easy to use in various in vitro applications, yielding consistent data across experiments.
For researchers and clinicians looking to dissect complex biological networks or explore novel therapeutic targets, our TTC39A Gene Knockout Cell Lines represent an invaluable tool in advancing both basic research and clinical applications. With a commitment to excellence and innovation in biological products, our company stands at the forefront of genetic research solutions, ensuring that our clientele has access to high-quality research models that drive scientific discovery forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.